Printer Friendly

Articles from Contract Pharma (May 1, 2012)

1-37 out of 37 article(s)
Title Author Type Words
2012 BIO convention heads to Boston: ICSE USA makes its debut in Philadelphia. 1329
2012 Outsourcing survey. 746
AAIPharma Services opens new Technology Center. 193
Access to biosimilars: patient access issues a opportunities. Howell, Peyton R. 1515
Agilent introduces SureFISH probes: Sartorius, Trace Analytics in private label pact. 718
Annual outsourcing survey. Survey 400
Baxter expands biologics capacity. 231
Bio-CMO industry trends: recent initiatives in biopharma contract manufacturing. Downey, William Company overview 2529
Bio-growth slowing? A new report details bio-outsourcing trends in 2012. Langer, Eric Survey 2139
Biosimilar outsourcing update: FDA's draft guidance leads to new opportunities. Roth, Gil Company overview 3304
Bosch introduces redesigned FLT via filler. 252
Catalent, BASF in bioavailability pact: Sanofi, Fox Foundation in Parkinson's pact. Company overview 1633
Catalent, Nascent to develop antibodies. 224
Company showcase. 3717
Discovering discovery? CMOs get spirited on discovery models. Harachand, S. 833
Drug interaction studies: a new FDA draft guidance reflects a fast-changing field. Bode, Chris 1919
Export controls and the biotech industry: are you in compliance? McClafferty, Eric; Ringel, Brooke Company overview 4722
Expression technologies: to outsource or license? White, Joel 1493
Heating up the global cold chain: USP's packaging, storage & distribution committee turns up the heat. O'Donnell, Kevin 908
Here comes the JOBS Act: watch out for unintended consequences. Martorelli, Michael A. 647
In the pipeline - health care reform and the drug industry: how goes it? 618
Less effort, more results? The busy-ness of business. Lowe, Derek B. 1234
Lonza names new CEO: Hospira appoints operations SVP. 1677
Lonza to make talactoferrin for Agennix. 193
Mandatory pre-dissemination review: FDA releases guidance on direct-to-consumer TV advertisements. Heisey, Colleen; Bradley, Sharon M. 1578
Merck Serono to close Geneva HQ: Cetero, FDA reach final resolution on bioanalytical data. 523
No quick fixes: will J&J and Novartis admit they face uphill climbs? Silverman, Ed 1490
Patheon's CEO speaks: Jim Mullen talks about his first year as a CDMO. Roth, Gil Y. Interview 3678
Quintiles names new CEO: CenterWatch study shows signs of clinical recovery. 798
San Diego hosts 2012 AAPS Biotech: drug development experts convene to address R&D strategies. 636
Sartorius, Trace Analytics in private label pact. 212
Takeda to acquire URL Pharma: Amgen acquires KAI pharmaceutical. 1668
Temperature-sensitive pharma concerns: avoiding the top 10 supply chain pitfalls. Bates, Justin 1622
The FDA says you are responsible: ... but do you know who you are? Atkinson, E. Morrey 1020
The hidden interview: balancing classic and hidden agendas. Jensen, David G. 1291
Warning letters galore: causes and prevention: what can we learn from the mistakes of others? Lush, Martin 3637
Who executes the executives? Changeover issues at pharma ... or conspiracy? Roth, Gil 722

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters